Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 4 1Phase 2 1Phase 1 1

Status

Completed 2Terminated 1

Sponsor Class

NETWORK 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 1Genitourinary 1

Conditions

Prostatic Neoplasms 1Neoplasm Metastasis 1Myasthenia Gravis 1Lymphoma, Follicular 1Lymphoma 1

Interventions

Cisplatin 187Carboplatin 182Paclitaxel 177Docetaxel 145Cyclophosphamide 129Dexamethasone 117pembrolizumab 106Doxorubicin 103Bevacizumab 103Gemcitabine 102Rituximab 96Prednisone 87Fluorouracil 86Pemetrexed 82Radiotherapy 77Vincristine 71Etoposide 71Capecitabine 69Nivolumab 68Trastuzumab 67Leucovorin 64Cytarabine 57Methotrexate 52Oxaliplatin 49atezolizumab 48Lenalidomide 43Ipilimumab 40Filgrastim 40Bortezomib 39Sorafenib 38

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Has results × Steroids × Clear all
NCT00006721 2026-03-16

S0016 Combination Chemotherapy With Monoclonal Antibody Therapy in Newly Diagnosed Non-Hodgkin's Lymphoma

SWOG Cancer Research Network

Phase 3 Completed
571 enrolled 12 charts
Lymphoid

Lymphoma, Lymphoma, Follicular

NCT00134056 2021-10-27

S0421, Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy

SWOG Cancer Research Network

Phase 3 Completed
1,038 enrolled 20 charts
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT00995722 2017-06-02

EPITOME'

University of Miami

Phase 3 Terminated
11 enrolled 14 charts

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡